Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system
This retrospective study of 481 women found a 9.6% spontaneous levonorgestrel-releasing intrauterine system expulsion rate, higher in those with adenomyosis, uterine leiomyoma, heavy bleeding, dysmenorrhea, or prior GnRH agonist use.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (25)
- Malpositioned intrauterine contraceptive devices: risk factors, outcomes, and future pregnancies via openalex
- The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis via openalex
- W1969496195 via openalex
- W1997276321 via openalex
- W2001265334 via openalex
- W2034686574 via openalex
- W2037716562 via openalex
- W2038493212 via openalex
- W2039466335 via openalex
- W2043888544 via openalex
- W2046921112 via openalex
- W2083325296 via openalex
- W2090979444 via openalex
- W2091349277 via openalex
- W2125849181 via openalex
- W2125950103 via openalex
- W2143209169 via openalex
- W2161599797 via openalex
- W2229502363 via openalex
- W4243609801 via openalex
- W4285719527 via openalex
- W6678970468 via openalex
- W1496034181 via openalex
- W6688967483 via openalex
- W1606787363 via openalex
Cited by (24)
- Case report and literature analysis on individualized hysteroscopic management of complex Müllerian anomalies complicated by bilateral adenomyosis 2026
- Levonorgestrel Intrauterine Device versus Combined Transcervical Resection of the Endometrium in the Management of Adenomyosis: A Randomized Clinical Trial 2026
- A case report of removal and uterine suturing of an incarcerated intrauterine sterilization ring 2026
- Efficacy and safety of combined GnRH-a, hysteroscopic surgery, and LNG-IUS for adenomyosis with suboptimal HIFU ablation: a retrospective study 2026
- Acceptability and clinical outcomes of levonorgestrel-releasing intrauterine system in the management of abnormal uterine bleeding among perimenopausal women: a prospective interventional study 2026
- High-intensity focused ultrasound combined with hysteroscopic insertion of levonorgestrel-releasing intrauterine system for intrinsic adenomyosis: a retrospective observational study 2025
- Comparison of safety and efficacy of hysteroscopic LNG-IUS fixation surgery and conventional LNG-IUS placement in the treatment of adenomyosis: A retrospective cohort study 2025
- Progressively optimized fixation method for levonorgestrel-releasing intrauterine device 2025
- An Innovative Surgical Technique: Anchoring Levonorgestrel-Releasing Intrauterine System Using a Specialized Fixation Needle 2025
- Simple and Novel Technique of Fixation for Levonorgestrel-Releasing Intrauterine Device for the Treatment of Uterine Adenomyosis 2024
- Clinical application of a simplified hysteroscopic LNG-IUD non-suture fixation in the treatment of adenomyosis 2024
- Efficacy and safety of dienogest versus GnRH-a combined with dienogest therapy for adenomyosis 2023
- Comparison of recurrence rate and risk factors in patients with focal adenomyosis with and without medical treatment after conservative surgery 2022
- Combined administration of Dienogest and Levonorgestrel – Releasing Intrauterine System Mirena 2022
- Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI) 2022
- Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up 2022
- Adenomyosis in Adolescence 2022
- The Medical Treatment of Adenomyosis 2021
- Effect of modified levonorgestrel-releasing intrauterine system in human adenomyosis with heavy menstrual bleeding 2021
- Indications and reasons for discontinuing the levonorgestrel-releasing intrauterine system (LNG-IUS) 2020
- [Efficacy and adverse effects of levonorgestrel-releasing intrauterine system in treatment of adenomyosis] 2019
- Drug therapy for adenomyosis: a prospective, nonrandomized, parallel-controlled study 2018
- Heavy menstrual bleeding diagnosis and medical management 2017
- EMAS position statement: management of uterine fibroids 2014
Source provenance
- europepmc
- last seen: 2026-10-09T06:09:53.026058+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:13:42.918798+00:00